Clinical trials: Dominantly Inherited Stargardt's Disease (STGD3)
Dominantly Inherited Stargardt's Disease (STGD3)
DHA Supplementation in Patients With STGD3
We have found that biomarkers of long-term elevated dietary intake of omega-3 fatty acids such as DHA and EPA are inversely associated with severity of disease phenotype in STGD3 patients.
- Trial name
- NCT00420602
- Testing
- Over the counter DHA/EPA dietary supplementation
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of Utah